Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHNS3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,805
Award facts
- Contract value 100% obligated
- $19,804.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $19,804.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The award, issued on December 9, 2025, with an ultimate completion date of December 31, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide.
The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, comprising a 30-month base period with three optional 30-month periods. Under this framework, the Defense Logistics Agency is authorized to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support recurring medical supply needs across the military healthcare system globally. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability to fulfill the diverse and specialized pharmaceutical requirements essential to Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FHNS3?
SPE2DR26FHNS3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FHNS3 worth?
The government has obligated $19,805 on SPE2DR26FHNS3.
Is contract SPE2DR26FHNS3 an order under another contract?
Yes. SPE2DR26FHNS3 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNS3 competed?
The extent of competition for SPE2DR26FHNS3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award